×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SYNCOM FORMULATIONS (INDIA) LT | 1315.7 | 130.02 | 1275.33 | 0.14 | 1,598 | 40.8 |
| BLISS GVS PHARMA LTD. | 2256.83 | 258.03 | 2104.18 | 2.27 | 1482 | 17.5 |
| JAGSONPAL PHARMACEUTICALS LTD. | 763.47 | 319.9 | 740.25 | 4.74 | 1458 | 40.0 |
Syncom Formulations (India) Ltd., with Security Code 524470, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.4 | 54.4 | 57.3 | 61.3 | 59.3 | 62.3 | 63.3 | 73.2 | 86.8 | 101.4 |
| Expenses | 47.9 | 50.2 | 51.5 | 55.4 | 53.2 | 56.3 | 56.5 | 64.5 | 76.4 | 89.6 |
| Operating Profit | 3.5 | 4.3 | 5.9 | 5.9 | 6.2 | 6.1 | 6.8 | 8.8 | 10.5 | 11.9 |
| OPM % | 6.78% | 7.87% | 10.29% | 9.68% | 10.37% | 9.76% | 10.74% | 12.02% | 12.06% | 11.75% |
| Other Income | 3.0 | 2.9 | 2.0 | 6.8 | 1.9 | 4.0 | 4.3 | 2.9 | 1.3 | 4.2 |
| Interest | 0.5 | 0.6 | 0.7 | 1.3 | 1.1 | 1.1 | 1.1 | 1.2 | 0.4 | 0.2 |
| Depreciation | 1.0 | 1.2 | 1.2 | 1.2 | 1.1 | 0.9 | 1.4 | 1.3 | 1.3 | 1.3 |
| Profit before tax | 5.0 | 5.4 | 6.0 | 10.3 | 5.8 | 8.1 | 8.6 | 9.2 | 10.1 | 14.7 |
| Tax % | 22.1% | 33% | 30.5% | 17.6% | 26.9% | 23.8% | 25.3% | 26.7% | 24.4% | 25.3% |
| Net Profit | 3.9 | 3.6 | 4.1 | 8.5 | 4.2 | 6.2 | 6.4 | 6.7 | 7.6 | 11.0 |
| EPS in Rs | 0.03 | 0.06 | 0.06 | 0.1 | 0.07 | 0.08 | 0.09 | 0.09 | 0.11 | 0.16 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.5 | 57.4 | 61.0 | 59.8 | 63.8 | 65.1 | 74.6 | 87.3 | 102.3 | 127.5 |
| Expenses | 50.2 | 51.5 | 55.0 | 53.4 | 57.4 | 57.8 | 65.2 | 76.8 | 90.2 | 112.8 |
| Operating Profit | 4.3 | 5.9 | 6.0 | 6.5 | 6.4 | 7.4 | 9.4 | 10.5 | 12.2 | 14.7 |
| OPM % | 7.9% | 10.3% | 9.8% | 10.8% | 10% | 11.3% | 12.6% | 12% | 11.9% | 11.6% |
| Other Income | 2.9 | 2.0 | 6.8 | 1.9 | 4.0 | 4.5 | 3.1 | 1.3 | 4.1 | 4.0 |
| Interest | 0.6 | 0.7 | 1.3 | 1.1 | 1.1 | 1.1 | 1.2 | 0.4 | 0.2 | 0.2 |
| Depreciation | 1.2 | 1.2 | 1.2 | 1.1 | 0.9 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 |
| Profit before tax | 5.4 | 6.0 | 10.3 | 6.1 | 8.5 | 9.4 | 10.0 | 10.1 | 14.9 | 17.3 |
| Tax % | 33% | 30.5% | 17.6% | 28.1% | 22.9% | 25.2% | 26.2% | 24.5% | 25.2% | 24.7% |
| Net Profit | 3.6 | 4.1 | 8.5 | 4.4 | 6.5 | 7.0 | 7.4 | 7.6 | 11.1 | 13.0 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | 2% |
| TTM: | 57% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 16% |
| 3 Years: | -7% |
| TTM: | 50% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 90% |
| 3 Years: | 20% |
| 1 Year: | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 56% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 48% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 90% |
| 3 Years: | 20% |
| 1 Year: | 13% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|